Julien Thery

Centre Oscar Lambret

Papers

1

Total Citations

34

H-Index

1

About

Julien Thery is a leading figure in gynecologic oncology, with a focused research program dedicated to improving surgical outcomes for women with cancer. His most prominent contribution is the landmark ROBOGYN-1004 trial, a randomized study that rigorously compared robot-assisted laparoscopy to conventional laparoscopy. This work, which has garnered over 34 citations, provided critical, evidence-based insights into severe perioperative morbidity, directly influencing clinical decision-making and surgical standards in the field. Thery’s research addresses a key translational gap, moving beyond feasibility studies to deliver high-quality data on patient safety and recovery. By clarifying the risks and benefits of advanced surgical technologies, his work helps surgeons and patients make more informed choices. His commitment to rigorous trial design and patient-centered outcomes positions him as a key voice in the ongoing evolution of minimally invasive gynecologic surgery, where his findings continue to shape best practices and future research directions.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial
34 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Centre Oscar Lambret

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago